ATLANTA, July 10, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1 today reported preliminary month-end assets under management (AUM) of $2,001.4 billion, an increase of 3.0% versus previous month-end. The firm delivered net long-term inflows of $8.3 billion in the month. Non-management fee earning net outflows were $1.5 billion and money market net outflows were $10.6 billion. AUM was positively impacted by favorable market returns which increased AUM by $58 billion. FX and reinvested distributions increased ...

Core Viewpoint - The Invesco Pharmaceuticals ETF (PJP) is a smart beta ETF designed to provide broad exposure to the healthcare sector, specifically focusing on U.S. pharmaceutical companies [1][5][6]. Fund Overview - PJP was launched on June 23, 2005, and has accumulated over $239.95 million in assets, categorizing it as an average-sized ETF within the healthcare sector [1][5]. - The fund aims to match the performance of the Dynamic Pharmaceutical Intellidex Index, which evaluates companies based on various investment merit criteria [5][6]. Cost and Expenses - PJP has an annual operating expense ratio of 0.56%, which is competitive with most peer products in the healthcare ETF space [7]. - The fund offers a 12-month trailing dividend yield of 1.16% [7]. Sector Exposure and Holdings - The ETF is fully allocated to the healthcare sector, with approximately 100% of its portfolio dedicated to this area [8]. - Eli Lilly & Co (LLY) constitutes about 5.41% of the fund's total assets, followed by Amgen Inc (AMGN) and Pfizer Inc (PFE). The top 10 holdings represent approximately 46.64% of total assets [9]. Performance Metrics - As of July 10, 2025, PJP has gained roughly 0.8% year-to-date and approximately 2.82% over the past year [11]. - The fund has traded between $74.59 and $89.61 in the last 52 weeks, with a beta of 0.47 and a standard deviation of 15.71% over the trailing three-year period, indicating a higher risk profile compared to peers [11]. Alternatives - Other ETFs in the pharmaceutical space include iShares U.S. Pharmaceuticals ETF (IHE) and VanEck Pharmaceutical ETF (PPH), which have lower expense ratios of 0.39% and 0.36%, respectively [13]. - Investors seeking lower-risk options may consider traditional market cap weighted ETFs that aim to match healthcare sector returns [13].

Group 1 - Invesco Mortgage Capital (NYSE: IVR) is a mortgage REIT that has been re-rated from Buy to Hold due to concerns about capital allocation in Q1 [1] - The analysis is based on value investing principles, an owner's mindset, and a long-term investment horizon [1] - The author does not engage in short selling and focuses on providing research without writing sell articles [1] Group 2 - There is no stock, option, or similar derivative position held by the author in any of the companies mentioned, nor any plans to initiate such positions in the near future [2] - The article reflects the author's own opinions and is not influenced by any business relationships with the companies discussed [2]

Market Volatility & Investment Strategy - Amid rising tariffs, geopolitical tensions, and economic uncertainty, long-term investors should stay focused and invested [1] - Investors should avoid letting headlines dictate their portfolio [1] - Clarity, not calm, is what markets crave [1] Economic Factors - Discussion includes inflation, potential rate cuts, and housing pressure [1] - The evolving US-China trade dynamic is a key consideration [1] Investment Advice Disclaimer - The podcast is for informational and educational purposes only and should not be construed as investment advice [1] - Listeners should consult their own financial, legal, or tax advisors [1]

ATLANTA, July 1, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) will release its second quarter 2025 results on Tuesday, July 22. The earnings release and presentation materials are scheduled to be released and posted to the Investor Relations section of the Company's website, www.invesco.com/corporate, at approximately 7 a.m. ET. A conference call to discuss Invesco's results will be held at 9 a.m. ET on that day; the live audio webcast and replay can be accessed through the same website under Events and Ea ...

Investment Strategy & Market Analysis - GARP (Growth at a Reasonable Price) ETFs seek to invest in stocks with strong growth potential trading at attractive prices, combining growth and value investing [1] - The strategy is relevant due to concerns about stretched valuations after market rallies [1] - Peter Lynch's success with Fidelity Magellan Fund (29% average annual return from 1977-1990) popularized GARP principles [1] ETF Performance & Methodology - iShares MSCI USA Quality GARP ETF (GARP) has a 015% expense ratio and holds 135 stocks, focusing on value, quality, and growth [1] - Invesco S&P 500 GARP ETF (SPGP) has a 036% expense ratio and holds 75 S&P 500 stocks selected by growth, quality, and value [1] - From January 2020, iShares GARP ETF is up approximately 147%, outperforming the S&P 500 index (up about 100%), while Invesco's product is up about 78% [1] - Year-to-date, iShares GARP ETF is up about 7%, the S&P 500 index is up a little less than 6%, and Invesco's product is up about 3% [2] Portfolio Composition & Sector Exposure - iShares GARP ETF's top holdings include Nvidia, Microsoft, and Apple, with 47% of the portfolio in information technology [1] - Invesco S&P 500 GARP ETF's top sector is consumer discretionary (about 21%), with a lower weight in information technology (about 20%) and a higher weight in energy [1]

Core Viewpoint - The Vanguard Growth ETF (VUG) is a popular choice for investors, tracking the CRSP US Large Cap Growth Index, which includes growth stocks from the S&P 500 [1] Group 1: ETF Composition and Performance - The Vanguard Growth ETF holds approximately 166 stocks, while its value counterpart, the Vanguard Value ETF (VTV), contains 331 stocks [2] - The Vanguard Growth ETF is heavily weighted in technology, with tech stocks making up 58.5% of its portfolio, and its top three holdings—Microsoft, Nvidia, and Apple—account for nearly 32% of its total holdings [3] - Over the past decade, the Vanguard Growth ETF has achieved an average annual return of 15.3%, outperforming the Vanguard S&P 500 ETF (12.8%) and the Vanguard Value ETF (10%) [5] Group 2: Comparison with Invesco QQQ Trust - The Invesco QQQ Trust has outperformed both the Vanguard 500 ETF and the Vanguard Growth ETF over the past decade, generating an average annual return of 17.7% [7] - The Invesco QQQ Trust is also tech-heavy, with 57.2% of its portfolio in the technology sector, but is less top-heavy than the Vanguard Growth ETF, with its top three holdings representing less than 25% of its portfolio [10] - The top holdings of the Vanguard Growth ETF and Invesco QQQ Trust are similar, but the weightings differ, with Microsoft at 11.3%, Nvidia at 10.3%, and Apple at 10.1% for Vanguard Growth, compared to 8.8%, 8.7%, and 7.3% for Invesco QQQ [11] Group 3: Investment Strategy - Both the Vanguard Growth ETF and Invesco QQQ Trust are suitable for growth investors, but the Invesco QQQ Trust is preferred due to its superior performance and less concentration in top holdings [12]

ETF Market Trends & Flows - VOO (Vanguard S&P 500 ETF) took in $14.5 billion last week, while IVV (iShares Core S&P 500 ETF) experienced outflows of $22.6 billion [2] - BND (Vanguard Total Bond Market ETF) also saw inflows, indicating appetite for bonds [2] - QQQ (Invesco QQQ Trust) experienced outflows of $1.9 billion [3] - ETFs charging 10 basis points or less are receiving less than half of the flows so far this year, a shift from previous years [22] - Leveraged ETF trade volume is near a record [23] Active vs Passive ETFs - Active ETFs now represent 51% of the marketplace, overtaking passively managed strategies in terms of the number of products [4] - Active ETFs are capturing 40% of net flows despite representing only 10% of assets, and are the majority of new launches [17] - BlackRock is one of the largest holders of active ETFs and has about 27 active ETF providers in its model portfolios [18][19] Investment Strategies & Portfolio Allocation - BlackRock rebalanced portfolios, increasing active bets on the equity overweight, specifically on the active ETF side [7] - BlackRock maintains treasuries as part of the risk-off portion of its portfolio but has recently added international developed bonds [12] - BlackRock added a 1% to 2% allocation to IBIT (iShares Bitcoin Trust) in portfolios that invest in alternatives [20] - Commodities should have a constant allocation in a portfolio to hedge against inflation and geopolitical risk [35][36] Oil Market & Geopolitical Risks - The conflict between Iran and Israel has been boosting crude energy prices [33] - The Invesco DB Oil Fund (DBO) tracks futures contracts on WTI and mitigates negative roll yield, with $224 million in total assets and a 076% expense ratio [31] - Geopolitical risks, particularly related to Iran and Russia/Ukraine, highlight the importance of having commodities like DBO in a portfolio [39] European Market - European defense is a growing theme, with $11 billion invested in the area due to the situation with Russia, Ukraine, and increased defense spending [26] - Year-to-date, Europe is up 23% while the U S is up 3% [28]

we discuss ideas like this as they happen in more detail. All active investors are welcome to join on a free trial and ask any question in our chat room full of sophisticated traders and investors.Today, we will look at the Invesco Variable Rate Preferred ETF (NYSEARCA: VRP ) portfolio and its holdings and try to make a guess about what kind of return we can expect from its portfolio in theAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and n ...

Core Insights - Invesco Commercial Real Estate Finance Trust, Inc. (INCREF) has provided $354.6 million in financing to Bridge Logistics Properties (BLP) for refinancing an industrial assets portfolio [1][3] - The portfolio consists of 24 properties totaling 2,454,761 square feet located in key states including California, Washington, Texas, New Jersey, New York, and Florida [2] - This financing aligns with INCREF's strategy of originating high-quality, income-generating loans secured by institutional quality assets in liquid markets across the US and Europe [3] Company Overview - INCREF is a perpetual life real estate investment trust focused on private credit secured by real estate, managed by Invesco Advisers, Inc. [4] - Invesco Real Estate, a global leader in real estate investment management, manages $85 billion in real estate assets and has a workforce of 605 employees across 21 regional offices [5] - Bridge Logistics Properties is a vertically integrated logistics real estate investment manager founded in 2021, led by experienced professionals from notable firms [7][8] Financial Strategy - The loan provided to BLP is characterized as a sub-70% loan-to-value loan secured by a diversified portfolio of well-leased, cash-flowing industrial properties [3] - With this financing, INCREF's portfolio now totals 61 loans representing over $3.6 billion in loan commitments across the US and Europe [3] Market Position - BLP focuses on value-driven investment strategies and collaborates closely with institutional capital partners, targeting coastal and gateway markets in the US [8] - Bridge Investment Group, the parent company of BLP, manages approximately $49 billion in assets and operates across various specialized asset classes [10]